2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model.
Saved in:
| Title: | 2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model. |
|---|---|
| Authors: | Salah, S.1 (AUTHOR), Kobayashi, T.2 (AUTHOR), Ito, K.2 (AUTHOR), Kita, Y.2 (AUTHOR), Horani, M.3 (AUTHOR), Alshangiti, A.1 (AUTHOR), Abu Hijlih, R.4 (AUTHOR), Sammour, M.5 (AUTHOR), Abuhijla, F.4 (AUTHOR), Al-Rabi, K.5 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1159-S1159. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179693429 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Salah%2C+S%2E%22">Salah, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kobayashi%2C+T%2E%22">Kobayashi, T.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ito%2C+K%2E%22">Ito, K.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kita%2C+Y%2E%22">Kita, Y.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Horani%2C+M%2E%22">Horani, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alshangiti%2C+A%2E%22">Alshangiti, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abu+Hijlih%2C+R%2E%22">Abu Hijlih, R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sammour%2C+M%2E%22">Sammour, M.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abuhijla%2C+F%2E%22">Abuhijla, F.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al-Rabi%2C+K%2E%22">Al-Rabi, K.</searchLink><relatesTo>5</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS1159-S1159. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179693429 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2024.08.2094 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S1159 Titles: – TitleFull: 2008P Assessing response durability and survival after second-line pembrolizumab in advanced urothelial carcinoma: A multicenter validation of a risk model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Salah, S. – PersonEntity: Name: NameFull: Kobayashi, T. – PersonEntity: Name: NameFull: Ito, K. – PersonEntity: Name: NameFull: Kita, Y. – PersonEntity: Name: NameFull: Horani, M. – PersonEntity: Name: NameFull: Alshangiti, A. – PersonEntity: Name: NameFull: Abu Hijlih, R. – PersonEntity: Name: NameFull: Sammour, M. – PersonEntity: Name: NameFull: Abuhijla, F. – PersonEntity: Name: NameFull: Al-Rabi, K. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2024 Supplement 2 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 35 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
